van der Pijl, J W <br/><br/>
Effect of danaparoid sodium on proteinuria, von Willebrand factor, and hard exudates in patients with diabetes mellitus type 2.  [electronic resource] 

 -  Journal of the American Society of Nephrology : JASN  Jun 1999 
 - 1331-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1046-6673 
<br/><br/><label>Standard No.: </label>10.1681/ASN.V1061331  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Anticoagulants--administration & dosage<br/>Chondroitin Sulfates--administration & dosage<br/>Dermatan Sulfate--administration & dosage<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Diabetic Nephropathies--drug therapy<br/>Diabetic Retinopathy--drug therapy<br/>Double-Blind Method<br/>Drug Combinations<br/>Endothelium, Vascular--metabolism<br/>Exudates and Transudates--drug effects<br/>Female<br/>Follow-Up Studies<br/>Heparitin Sulfate--administration & dosage<br/>Humans<br/>Kidney Function Tests<br/>Male<br/>Middle Aged<br/>Proteinuria--drug therapy<br/>Reference Values<br/>Statistics, Nonparametric<br/>von Willebrand Factor--drug effects